ABL1 |
P00519
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
Kinase
|
1.00 |
0.432 |
0.923 |
AKT1 |
P31749
|
AKT serine/threonine kinase 1
|
Kinase
|
0.98 |
0.311 |
0.962 |
ARID1A |
O14497
|
AT-rich interaction domain 1A
|
|
1.00 |
0.455 |
0.846 |
ATM |
Q13315
|
ATM serine/threonine kinase
|
Kinase
|
5.6E-47 |
0.374 |
0.885 |
BCL10 |
O95999
|
BCL10 immune signaling adaptor
|
|
0.34 |
0.491 |
0.769 |
BCR |
P11274
|
BCR activator of RhoGEF and GTPase
|
Enzyme modulator
|
0.99 |
0.431 |
0.885 |
BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
CARD11 |
Q9BXL7
|
caspase recruitment domain family member 11
|
|
1.00 |
0.582 |
0.615 |
CCL5 |
P13501
|
C-C motif chemokine ligand 5
|
Signaling
|
1.8E-03 |
0.403 |
0.885 |
CCND1 |
P24385
|
cyclin D1
|
Enzyme modulator
|
0.89 |
0.344 |
0.923 |
CD28 |
P10747
|
CD28 molecule
|
|
0.36 |
0.436 |
0.885 |
CD40 |
P25942
|
CD40 molecule
|
|
0.85 |
0.396 |
0.846 |
CD40LG |
P29965
|
CD40 ligand
|
Signaling
|
0.72 |
0.414 |
0.846 |
CD44 |
P16070
|
CD44 molecule (Indian blood group)
|
|
2.4E-07 |
0.363 |
0.962 |
CDKN1B |
P46527
|
cyclin dependent kinase inhibitor 1B
|
|
0.62 |
0.409 |
0.769 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CDKN2B |
P42772
|
cyclin dependent kinase inhibitor 2B
|
|
7.3E-03 |
0.417 |
0.769 |
CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
CREBBP |
Q92793
|
CREB binding protein
|
|
1.00 |
0.428 |
0.808 |
CXCL8 |
P10145
|
C-X-C motif chemokine ligand 8
|
Signaling
|
2.7E-04 |
0.310 |
0.962 |
FAS |
P25445
|
Fas cell surface death receptor
|
|
0.81 |
0.372 |
0.923 |
FOXP3 |
Q9BZS1
|
forkhead box P3
|
|
0.99 |
0.368 |
0.846 |
HLA-DQB1 |
P01920
|
major histocompatibility complex, class II, DQ beta 1
|
Immune response
|
8.9E-03 |
0.407 |
0.885 |
HRAS |
P01112
|
HRas proto-oncogene, GTPase
|
Enzyme modulator
|
8.0E-02 |
0.378 |
0.885 |
IFNG |
P01579
|
interferon gamma
|
|
0.47 |
0.288 |
0.962 |